Previous 10 | Next 10 |
Biotricity, Inc. (BTCY) Q2 2023 Earnings Conference Call November 14, 2022 04:30 PM ET Company Participants Valter Pinto - Managing Director, KCSA Strategic Communications Waqaas Al-Siddiq - Chairman, Chief Executive Officer & Founder John Ayanoglou - Chief F...
Biotricity press release ( NASDAQ: BTCY ): Q2 GAAP EPS of -$0.09 misses by $0.01 . Revenue of $2.4M (+32.6% Y/Y) misses by $0.14M . For further details see: Biotricity GAAP EPS of -$0.09 misses by $0.01, revenue of $2.4M misses by $0.14M
Revenue totaled $2.4 million, up 14% sequentially quarter-over-quarter REDWOOD CITY, CA / ACCESSWIRE / November 14, 2022 / Biotricity Inc. (NASDAQ:BTCY) ("Biotricity" or the "Company"), a medical diagnostic and consumer healthcare technology company, today announced its financial result...
Bioheart provides consumers the most advanced personal heart monitoring technology, combining powerful analytics and continuous heart monitoring for personalized heart insights REDWOOD CITY, CA / ACCESSWIRE / November 10, 2022 / Biotricity Inc. (NASDAQ:BTCY) ("Biotricity" or the "Compan...
REDWOOD CITY, CA / ACCESSWIRE / November 1, 2022 / Biotricity Inc. (NASDAQ:BTCY) ("Biotricity" or the "Company"), a medical diagnostic and consumer healthcare technology company, today announced it will host a conference call on Monday, November 14, 2022 at 4:30 p.m. ET to discuss its financ...
Biocare Cardiac is the first-of-its-kind comprehensive cardiac disease management solution combining diagnostics, RPM, disease and lifestyle management, and telemedicine for cardiologists and patients. REDWOOD CITY, CA / ACCESSWIRE / October 26, 2022 / Biotricity, Inc. (NASDAQ:BTCY), a ...
REDWOOD CITY, CA / ACCESSWIRE / October 13, 2022 / Biotricity Inc. (NASDAQ:BTCY) ("Biotricity" or the "Company"), a medical diagnostic and consumer healthcare technology company, today announced that Waqaas Al-Siddiq, Founder and CEO, is scheduled to participate in a panel discussion...
Data set of 2 billion heartbeats and growing allows Biotricity to scale faster and operate more efficiently with better automation, yielding growth and better margins in the future REDWOOD CITY, CA / ACCESSWIRE / October 4, 2022 / Biotricity Inc. (NASDAQ:BTCY) ("Biotricity" or the "Com...
Bioflux-AI is an innovative artificial intelligence-driven (‘AI') system with real-time monitoring and prediction capabilities that will be used to investigate stroke episodes in Chronic Kidney Disease patients REDWOOD CITY, CA / ACCESSWIRE / September 7, 2022 / Biotricity Inc. (...
Biotricity press release ( NASDAQ: BTCY ): Q1 GAAP EPS of -$0.09. Revenue of $2.06M (+17.0% Y/Y). For further details see: Biotricity GAAP EPS of -$0.09, revenue of $2.06M
News, Short Squeeze, Breakout and More Instantly...
ORLANDO, FL / ACCESSWIRE / July 12, 2024 / RedChip Companies will air interviews with Biotricity, Inc. (Nasdaq:BTCY) and bioAffinity Technologies, Inc. (Nasdaq:BIAF) on the RedChip Small Stocks, Big Money™ show, a sponsored program on Bloomberg TV, this Saturday, July 13, at 7 p.m. East...
REDWOOD CITY, CA / ACCESSWIRE / July 11, 2024 / Biotricity Inc. (NASDAQ:BTCY), a Technology-as-a-Service (TaaS) company operating in the remote cardiac monitor sector of consumer healthcare, today announced its accelerated timeline to achieving EBITDA positive. The company now expects to reach t...
REDWOOD CITY, CA / ACCESSWIRE / July 10, 2024 / Biotricity Inc. (Nasdaq:BTCY), a Technology-as-a-Service (TaaS) company operating in the remote cardiac monitor sector of consumer healthcare, today announced the launch of a new cardiac monitoring pilot program with a prominent hospital group enco...